Stocker Roland, Keaney John F
Centre for Vascular Research, University of New South Wales, Sydney, New South Wales, Australia.
Physiol Rev. 2004 Oct;84(4):1381-478. doi: 10.1152/physrev.00047.2003.
This review focuses on the role of oxidative processes in atherosclerosis and its resultant cardiovascular events. There is now a consensus that atherosclerosis represents a state of heightened oxidative stress characterized by lipid and protein oxidation in the vascular wall. The oxidative modification hypothesis of atherosclerosis predicts that low-density lipoprotein (LDL) oxidation is an early event in atherosclerosis and that oxidized LDL contributes to atherogenesis. In support of this hypothesis, oxidized LDL can support foam cell formation in vitro, the lipid in human lesions is substantially oxidized, there is evidence for the presence of oxidized LDL in vivo, oxidized LDL has a number of potentially proatherogenic activities, and several structurally unrelated antioxidants inhibit atherosclerosis in animals. An emerging consensus also underscores the importance in vascular disease of oxidative events in addition to LDL oxidation. These include the production of reactive oxygen and nitrogen species by vascular cells, as well as oxidative modifications contributing to important clinical manifestations of coronary artery disease such as endothelial dysfunction and plaque disruption. Despite these abundant data however, fundamental problems remain with implicating oxidative modification as a (requisite) pathophysiologically important cause for atherosclerosis. These include the poor performance of antioxidant strategies in limiting either atherosclerosis or cardiovascular events from atherosclerosis, and observations in animals that suggest dissociation between atherosclerosis and lipoprotein oxidation. Indeed, it remains to be established that oxidative events are a cause rather than an injurious response to atherogenesis. In this context, inflammation needs to be considered as a primary process of atherosclerosis, and oxidative stress as a secondary event. To address this issue, we have proposed an "oxidative response to inflammation" model as a means of reconciling the response-to-injury and oxidative modification hypotheses of atherosclerosis.
本综述聚焦于氧化过程在动脉粥样硬化及其所致心血管事件中的作用。目前已达成共识,即动脉粥样硬化代表一种氧化应激增强的状态,其特征为血管壁中的脂质和蛋白质氧化。动脉粥样硬化的氧化修饰假说预测,低密度脂蛋白(LDL)氧化是动脉粥样硬化的早期事件,且氧化型LDL有助于动脉粥样硬化的发生。支持这一假说的证据包括:氧化型LDL可在体外促进泡沫细胞形成,人类病变中的脂质大量被氧化,有证据表明体内存在氧化型LDL,氧化型LDL具有多种潜在的促动脉粥样硬化活性,以及几种结构不相关的抗氧化剂可抑制动物的动脉粥样硬化。一个新出现的共识还强调了除LDL氧化之外,氧化事件在血管疾病中的重要性。这些事件包括血管细胞产生活性氧和氮物种,以及氧化修饰导致冠状动脉疾病的重要临床表现,如内皮功能障碍和斑块破裂。然而,尽管有这些丰富的数据,但将氧化修饰视为动脉粥样硬化(必要的)病理生理重要原因仍存在一些基本问题。这些问题包括抗氧化策略在限制动脉粥样硬化或动脉粥样硬化所致心血管事件方面效果不佳,以及在动物实验中的观察结果表明动脉粥样硬化与脂蛋白氧化之间存在分离。事实上,氧化事件是动脉粥样硬化的原因而非损伤反应这一点仍有待确定。在这种情况下,炎症应被视为动脉粥样硬化的主要过程,而氧化应激则为次要事件。为解决这一问题,我们提出了一种“炎症氧化反应”模型,作为调和动脉粥样硬化的损伤反应假说和氧化修饰假说的一种方式。